Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient received vaccine from a Moderna Covid-19 vial that had been punctured more than 12 hours ago on April 20, 2023 lot number 011H22A expiration date May 23, 2023 patient received the; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine from a Moderna Covid-19 vial that had been punctured more than 12 hours ago on April 20, 2023 lot number 011H22A expiration date May 23, 2023 patient received the) and NO ADVERSE EVENT (No adverse event) in a 56-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 011H22A) for COVID-19 prophylaxis.     Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (lot number 001M21A expiration date was July 10, 2022  patient received the vaccine in his left arm) on 26-Apr-2022, MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) (lot number AS7145B expiration date May 14, 2023  patient received in left arm) on 13-Sep-2022 and Moderna COVID-19 Vaccine. Past adverse reactions to the above products included No adverse event with MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5), Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine.    On 20-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine from a Moderna Covid-19 vial that had been punctured more than 12 hours ago on April 20, 2023 lot number 011H22A expiration date May 23, 2023 patient received the). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine from a Moderna Covid-19 vial that had been punctured more than 12 hours ago on April 20, 2023 lot number 011H22A expiration date May 23, 2023 patient received the) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received vaccine from a Moderna Covid-19 vial that had been punctured more than 12 hours ago on April 20, 2023 lot number 011H22A expiration date May 23, 2023 patient received the).    No concomitant medications was provided. No treatment medications was provided. Patient was immunocompromised. Patient received 4 Moderna Vaccines prior to today. The Pharmacist does not have information on any of the previous vaccinations. No adverse reactions reported for patient. Patient received vaccine from a Moderna Covid-19 vial that had been punctured more than 12 hours ago on April 20, 2023.